Skip to main content
SpringerLink
Log in

Enhanced Bioavailability of 6-Mercaptopurine After Rectal Administration in Rats

  • Note
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. S. Zimm, J. M. Collins, R. Riccardi, D. O'Neill, P. K. Narang, B. Chabner, and D. G. Poplack. Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N. Engl. J. Med. 308:1005–1009 (1983).

    Google Scholar 

  2. K. Kuroda, T. Yokoyama, T. Umeda, Y. Kita, A. Konishi, and T. Kuroda. Studies on drug nonequivalence. VIII. Solubilities of polymorphs and hydrate of mercaptopurine. Yakugaku Zasshi 99:745–751 (1979).

    Google Scholar 

  3. K. G. Van Scoik, C. A. Johnson, and W. R. Porter. The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathiopurine. Drug Metab. Rev. 16:157–174(1985).

    Google Scholar 

  4. R. Weinshilboum. Methyltransferase pharmacogenetics. Pharmacol. Ther. 43:77–90 (1989).

    Google Scholar 

  5. T. Yokoyama, T. Umeda, K. Kuroda, T. Kuroda, and S. Asada. Studies on drug nonequivalence. X. Bioavailability of 6-mercaptopurine polymorphs. Chem. Pharm. Bull. 29:194–199 (1981).

    Google Scholar 

  6. S. Zimm, J. M. Collins, D. O'Neill, B. A. Chabner, and D. G. Poplack. Inhibition of first-pass metabolism in cancer chemotherapy: Interaction of 6-mercaptopurine and allopurinol. Clin. Pharmacol. Ther. 34:810–817 (1983).

    Google Scholar 

  7. Y. Kato, T. Matsushita, T. Yokoyama, and K. Mohri. Studies on dosage forms of 6-mercaptopurine in a child with acute lymphoblastic leukemia. Jpn. J. Hosp. Pharm. 17:257–264 (1991).

    Google Scholar 

  8. Y. Kato, T. Matsushita, T. Yokoyama, and K. Mohri. Determination of 6-mercaptopurine in acute lymphoblastic leukemia patients' plasma by high performance liquid chromatography. Ther. Drug Monit. 13:220–225 (1991).

    Google Scholar 

  9. M. Gibaldi and D. Perrier. Pharmacokinetics, Marcel Dekker, New York, 1975, pp. 48–55.

    Google Scholar 

  10. K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A Pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4:879–885 (1981).

    Google Scholar 

  11. Y. Kato, T. Matsushita, K. Chiba, N. Hijiya, T. Yokoyama, and T. Ishizaki. Dose-dependent kinetics of orally administered 6-mercaptopurine in children with leukemia. J. Pediat. 119:311–316(1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, National Medical Center, Toyama 1-21-1, Shinjuku-ku, Tokyo, 162, Japan

    Yasuhisa Kato & Tomomasa Yokoyama

  2. Department of Pediatrics, National Medical Center, Toyama 1-21-1, Shinjuku-ku, Tokyo, 162, Japan

    Takeji Matsushita

  3. Department of Biopharmacy, Meiji College of Pharmacy, 1-35-23, Nozawa Setagaya-ku, Tokyo, 154, Japan

    Kiminori Mohri

Authors
  1. Yasuhisa Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takeji Matsushita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomomasa Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kiminori Mohri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kato, Y., Matsushita, T., Yokoyama, T. et al. Enhanced Bioavailability of 6-Mercaptopurine After Rectal Administration in Rats. Pharm Res 9, 697–699 (1992). https://doi.org/10.1023/A:1015874732029

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015874732029

Search

Navigation